Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Mar
2
2025
Connecticut Bill Addresses “Shrinkflation” Keller and Heckman LLP
Feb
28
2025
APHIS Will Begin Accepting Petitions for Nonregulated Status on March 3, 2025 Bergeson & Campbell, P.C.
Feb
28
2025
McDermott+ Check-Up: February 28, 2025 McDermott Will & Emery
Feb
27
2025
Florida Appellate Court Rules Hookah Products are Taxable OTP Jones Walker LLP
Feb
27
2025
A Regulatory Haze of Uncertainty Continues as the Clock Ticks Toward Phase One of FDA’s LDT Final Rule Epstein Becker & Green, P.C.
Feb
27
2025
TSCA Developments — A Conversation with Richard E. Engler, Ph.D. [Podcast] Bergeson & Campbell, P.C.
Feb
27
2025
Florida Court Rules That the Florida Constitution Requires Employers to Accommodate Off-Duty Medical Marijuana Use Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Feb
27
2025
This Week in 340B: February 18 – 24, 2025 McDermott Will & Emery
Feb
26
2025
Guiding Your Company Through Trump’s New Latin America Enforcement Policy Bracewell LLP
Feb
26
2025
Backwards Down the Number Line: Assessing the State of Alabama’s Medical Cannabis Program Four Years After Its Enactment Bradley Arant Boult Cummings LLP
Feb
26
2025
FTC COPPA Updates Provide New Protections for Children Sheppard, Mullin, Richter & Hampton LLP
Feb
26
2025
Lawsuit Alleges FDA Has Unduly Delayed Response to PFAS Petition Keller and Heckman LLP
Feb
26
2025
FDA Delays Effective Date for ‘Healthy’ Rule Keller and Heckman LLP
Feb
25
2025
GLP-1 Receptor Agonists: New Frontiers and Challenges Foley & Lardner LLP
Feb
25
2025
Food & Chemicals Unpacked: Making-up for Lost Time: FDA’s Increased Oversight of Cosmetics [Podcast] Keller and Heckman LLP
Feb
25
2025
GLP-1 Drugs: FDA Removes Semaglutide from the Drug Shortage List Foley & Lardner LLP
Feb
25
2025
A Deepened Divide: Appellate Court Joins False Claims Act Circuit Split in Favor of Health Care Defendants Polsinelli PC
Feb
25
2025
The Story of the Ghost: How a “Loophole” Created a Behemoth of Intoxicating Cannabis Products and What (If Anything) Congress Intends to Do About It Bradley Arant Boult Cummings LLP
Feb
24
2025
Opioids and Common Law Liability for Indirect Economic Harm Pierce Atwood LLP
Feb
24
2025
PFAS Lawsuit Against Industrial Users of PFAS Highlights Risks CMBG3 Law
Feb
23
2025
Multiple States Propose Bans on Food Additives and “Ultra-Processed Foods” Keller and Heckman LLP
Feb
21
2025
FDA Continues Push to Improve Food Labeling Practices in the United States Mintz
Feb
21
2025
McDermott+ Check-Up: February 21, 2025 McDermott Will & Emery
Feb
21
2025
Navigating the EPR Laws: What Alcohol Beverage Producers Need to Know McDermott Will & Emery
Feb
20
2025
Make Food “Healthy” Again: FDA’s Resolution for a Healthier 2025 Foley & Lardner LLP
Feb
20
2025
China on the Move: Lessons from China’s 2024 National Negotiation of Drug Prices Greenberg Traurig, LLP
Feb
20
2025
It’s The Hope That Kills You: My Experience with Alabama’s Medical Cannabis Experiment Bradley Arant Boult Cummings LLP
Feb
19
2025
This Week in 340B: February 11 – 17, 2025 McDermott Will & Emery
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters